97 related articles for article (PubMed ID: 25091631)
1. Both gene deletion and promoter hyper-methylation contribute to the down-regulation of ZAC/PLAGL1 gene in gastric adenocarcinomas: a case control study.
Li Z; Ding Y; Zhu Y; Yin M; Le X; Wang L; Yang Y; Zhang Q
Clin Res Hepatol Gastroenterol; 2014 Dec; 38(6):744-50. PubMed ID: 25091631
[TBL] [Abstract][Full Text] [Related]
2. Loss of expression of ZAC/PLAGL1 in diffuse large B-cell lymphoma is independent of promoter hypermethylation.
Valleley EM; Cordery SF; Carr IM; MacLennan KA; Bonthron DT
Genes Chromosomes Cancer; 2010 May; 49(5):480-6. PubMed ID: 20175198
[TBL] [Abstract][Full Text] [Related]
3. Promoter hypermethylation of CDH1, FHIT, MTAP and PLAGL1 in gastric adenocarcinoma in individuals from Northern Brazil.
Leal M; Lima E; Silva P; Assumpção P; Calcagno D; Payão S; Burbano RR; Smith M
World J Gastroenterol; 2007 May; 13(18):2568-74. PubMed ID: 17552003
[TBL] [Abstract][Full Text] [Related]
4. Tissue-specific imprinting of the ZAC/PLAGL1 tumour suppressor gene results from variable utilization of monoallelic and biallelic promoters.
Valleley EM; Cordery SF; Bonthron DT
Hum Mol Genet; 2007 Apr; 16(8):972-81. PubMed ID: 17341487
[TBL] [Abstract][Full Text] [Related]
5. LOT1 (PLAGL1/ZAC1), the candidate tumor suppressor gene at chromosome 6q24-25, is epigenetically regulated in cancer.
Abdollahi A; Pisarcik D; Roberts D; Weinstein J; Cairns P; Hamilton TC
J Biol Chem; 2003 Feb; 278(8):6041-9. PubMed ID: 12473647
[TBL] [Abstract][Full Text] [Related]
6. Altered expression of the PLAGL1 (ZAC1/LOT1) gene in colorectal cancer: Correlations to the clinicopathological parameters.
Kowalczyk AE; Krazinski BE; Godlewski J; Kiewisz J; Kwiatkowski P; Sliwinska-Jewsiewicka A; Kiezun J; Wierzbicki PM; Bodek G; Sulik M; Kmiec Z
Int J Oncol; 2015 Sep; 47(3):951-62. PubMed ID: 26134521
[TBL] [Abstract][Full Text] [Related]
7. Hypermethylation of XIAP-associated factor 1, a putative tumor suppressor gene from the 17p13.2 locus, in human gastric adenocarcinomas.
Byun DS; Cho K; Ryu BK; Lee MG; Kang MJ; Kim HR; Chi SG
Cancer Res; 2003 Nov; 63(21):7068-75. PubMed ID: 14612497
[TBL] [Abstract][Full Text] [Related]
8. Tumor suppressor gene ZAC/PLAGL1: altered expression and loss of the nonimprinted allele in pheochromocytomas.
Jarmalaite S; Laurinaviciene A; Tverkuviene J; Kalinauskaite N; Petroska D; Böhling T; Husgafvel-Pursiainen K
Cancer Genet; 2011 Jul; 204(7):398-404. PubMed ID: 21872827
[TBL] [Abstract][Full Text] [Related]
9. Loss of expression of the candidate tumor suppressor gene ZAC in breast cancer cell lines and primary tumors.
Bilanges B; Varrault A; Basyuk E; Rodriguez C; Mazumdar A; Pantaloni C; Bockaert J; Theillet C; Spengler D; Journot L
Oncogene; 1999 Jul; 18(27):3979-88. PubMed ID: 10435621
[TBL] [Abstract][Full Text] [Related]
10. Methylation-mediated repression of GADD45A and GADD45G expression in gastric cardia adenocarcinoma.
Guo W; Dong Z; Guo Y; Chen Z; Kuang G; Yang Z
Int J Cancer; 2013 Nov; 133(9):2043-53. PubMed ID: 23616123
[TBL] [Abstract][Full Text] [Related]
11. The human HYMAI/PLAGL1 differentially methylated region acts as an imprint control region in mice.
Arima T; Yamasaki K; John RM; Kato K; Sakumi K; Nakabeppu Y; Wake N; Kono T
Genomics; 2006 Nov; 88(5):650-8. PubMed ID: 16928428
[TBL] [Abstract][Full Text] [Related]
12. Frequent epigenetic inactivation of RASSF1A by aberrant promoter hypermethylation in human gastric adenocarcinoma.
Byun DS; Lee MG; Chae KS; Ryu BG; Chi SG
Cancer Res; 2001 Oct; 61(19):7034-8. PubMed ID: 11585730
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of PLAGL1-specific CpG site methylation in soft-tissue sarcomas.
Peille AL; Brouste V; Kauffmann A; Lagarde P; Le Morvan V; Coindre JM; Chibon F; Bresson-Bepoldin L
PLoS One; 2013; 8(11):e80741. PubMed ID: 24260468
[TBL] [Abstract][Full Text] [Related]
14. Altered expression and loss of heterozygosity of the LOT1 gene in ovarian cancer.
Cvetkovic D; Pisarcik D; Lee C; Hamilton TC; Abdollahi A
Gynecol Oncol; 2004 Dec; 95(3):449-55. PubMed ID: 15581945
[TBL] [Abstract][Full Text] [Related]
15. LOT1 (ZAC1/PLAGL1) and its family members: mechanisms and functions.
Abdollahi A
J Cell Physiol; 2007 Jan; 210(1):16-25. PubMed ID: 17063461
[TBL] [Abstract][Full Text] [Related]
16. Decreased expression and aberrant methylation of RASSF5A correlates with malignant progression of gastric cardia adenocarcinoma.
Han L; Dong Z; Wang C; Guo Y; Shen S; Kuang G; Guo W
Mol Carcinog; 2015 Dec; 54(12):1722-33. PubMed ID: 25420558
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic silencing of the imprinted gene ZAC by DNA methylation is an early event in the progression of human ovarian cancer.
Kamikihara T; Arima T; Kato K; Matsuda T; Kato H; Douchi T; Nagata Y; Nakao M; Wake N
Int J Cancer; 2005 Jul; 115(5):690-700. PubMed ID: 15751035
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of thyroid hormone receptor β1 gene expression in gastric cancer involves promoter methylation.
Ling Y; Shi X; Wang Y; Ling X; Li Q
Biochem Biophys Res Commun; 2014 Feb; 444(2):147-52. PubMed ID: 24434154
[TBL] [Abstract][Full Text] [Related]
19. Methylation status of imprinted genes DLK1-GTL2, MEST (PEG1), ZAC (PLAGL1), and LINE-1 elements in spermatozoa of normozoospermic men, unlike H19 imprinting control regions, is not associated with idiopathic recurrent spontaneous miscarriages.
Ankolkar M; Salvi V; Warke H; Vundinti BR; Balasinor NH
Fertil Steril; 2013 May; 99(6):1668-73. PubMed ID: 23415968
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic inactivation of deleted in lung and esophageal cancer 1 gene by promoter methylation in gastric and colorectal adenocarcinoma.
Zhang Y; Ye X; Geng J; Chen L
Hepatogastroenterology; 2010; 57(104):1614-9. PubMed ID: 21443130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
